These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer. Cai C; Zhu X Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855 [TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop between Wnt/β-catenin signaling and hTERT regulates the cancer stem cell-like traits in radioresistant nasopharyngeal carcinoma cells. Chen K; Chen L; Li L; Qu S; Yu B; Sun Y; Wan F; Chen X; Liang R; Zhu X J Cell Biochem; 2020 Nov; 121(11):4612-4622. PubMed ID: 32065421 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
11. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy. Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140 [TBL] [Abstract][Full Text] [Related]
12. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990 [TBL] [Abstract][Full Text] [Related]
13. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma. Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764 [TBL] [Abstract][Full Text] [Related]
14. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling. Su J; Wu S; Wu H; Li L; Guo T Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583 [TBL] [Abstract][Full Text] [Related]
15. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling. Wang B; Liu J; Ma LN; Xiao HL; Wang YZ; Li Y; Wang Z; Fan L; Lan C; Yang M; Hu L; Wei Y; Bian XW; Chen D; Wang J J Gastroenterol; 2013 Jul; 48(7):798-808. PubMed ID: 23188090 [TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44 Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850 [TBL] [Abstract][Full Text] [Related]
17. Ibuprofen reduces cell proliferation through inhibiting Wnt/β catenin signaling pathway in gastric cancer stem cells. Akrami H; Moradi B; Borzabadi Farahani D; Mehdizadeh K Cell Biol Int; 2018 Aug; 42(8):949-958. PubMed ID: 29512256 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma. Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941 [TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
20. Nuclear Accumulation of β-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer. Tanaka H; Kawaguchi M; Shoda S; Miyoshi T; Iwasaki R; Hyodo F; Mori T; Hara A; Tomita H; Matsuo M Anticancer Res; 2019 Dec; 39(12):6575-6583. PubMed ID: 31810923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]